Clinical Trials Directory

Trials / Completed

CompletedNCT06488417

Frankincense Supplements and Inflammation

Evaluation of Frankincense Essential Oil Supplements on Markers of Inflammation and Cellular Health

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
67 (actual)
Sponsor
dōTERRA International · Industry
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to learn whether frankincense essential oil-based supplements can affect gene expression and serum protein markers in healthy volunteers. The main questions it aims to answer are: 1. Do frankincense essential oil supplements affect gene expression and protein markers as measured in blood? 2. How does daily ingestion of frankincense supplements affect anthropometric measurements, including body mass index, waist circumference, blood pressure, and heart rate? 3. How does daily ingestion of frankincense essential oil supplements affect subjective quality of life and health parameters? 4. Is ingesting frankincense essential oil supplements daily safe, as measured by laboratory tests and adverse events? Researchers will compare two types of frankincense essential oil supplements. One type contains frankincense essential oil and boswellic acid as its active ingredients. The other type contains only frankincense essential oil as its active ingredient. Participants will: * Be assigned one of the two types of frankincense essential oil supplement * Take two capsules of their assigned supplement every day for about 30 days * Attend two study visits in which they provide blood and urine samples, complete subjective health and quality of life assessments, and undergo anthropometric measurements * Complete weekly subjective health assessments from home

Detailed description

This randomized, double-blind study will recruit healthy men and women to compare gene expression profile and serum protein markers before and after consumption of frankincense essential oil supplements for approximately 4 weeks. Quality of life will also be assessed using subjective surveys and questionnaires. Safety markers (liver and kidney function, hematology, urinalysis, and adverse events) will be collected.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFrankincense essential oil + boswellic acid supplementThis supplement contains frankincense essential oil and boswellic acid as its active ingredients.
DIETARY_SUPPLEMENTFrankincense essential oil supplementThis supplement contains frankincense essential oil as its active ingredient.

Timeline

Start date
2024-06-17
Primary completion
2024-08-12
Completion
2024-08-21
First posted
2024-07-05
Last updated
2024-08-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06488417. Inclusion in this directory is not an endorsement.